Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from review paper

  • You have access
    Understanding antipsychotic “atypicality”: a clinical and pharmacological moving target
    Gary Remington
    J Psychiatry Neurosci July 01, 2003 28 (4) 275-284;
  • You have access
    A review of olanzapine-associated toxicity and fatality in overdose
    Pierre Chue and Peter Singer
    J Psychiatry Neurosci July 01, 2003 28 (4) 253-261;
  • You have access
    The role of GABAA receptors in mediating the effects of alcohol in the central nervous system
    Martin Davies
    J Psychiatry Neurosci July 01, 2003 28 (4) 263-274;
  • You have access
    Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models
    Susan Rotzinger and Franco J. Vaccarino
    J Psychiatry Neurosci May 01, 2003 28 (3) 171-181;
  • You have access
    Interactions between the cytochrome P450 system and the second-generation antipsychotics
    Trevor I. Prior and Glen B. Baker
    J Psychiatry Neurosci March 01, 2003 28 (2) 99-112;
  • You have access
    Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer’s disease
    Krista L. Lanctôt, Nathan Herrmann and Maysoon M. LouLou
    J Psychiatry Neurosci January 01, 2003 28 (1) 13-26;
  • You have access
    Dopamine genes and attention-deficit hyperactivity disorder: a review
    Salvatore DiMaio, Nathalie Grizenko and Ridha Joober
    J Psychiatry Neurosci January 01, 2003 28 (1) 27-38;
  • You have access
    Genetics of schizophrenia: from animal models to clinical studies
    Ridha Joober, Patricia Boksa, Chawki Benkelfat and Guy Rouleau
    J Psychiatry Neurosci September 01, 2002 27 (5) 336-347;
  • You have access
    What’s in a name? The evolution of the nomenclature of antipsychotic drugs
    Caroline King and Lakshmi N.P. Voruganti
    J Psychiatry Neurosci May 01, 2002 27 (3) 168-175;
  • You have access
    Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale
    Sarah van Mastrigt and Jean Addington
    J Psychiatry Neurosci March 01, 2002 27 (2) 92-101;

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire